Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief research scientist Noll Campbell, PharmD, M.S., spoke about a common class of drugs and how it affects the brain on an Indianapolis radio show.

Dr. Campbell was a guest on Caregiver Crossing, which airs every Saturday on 93.1 WIBC. Dr. Campbell addressed the topic of anticholinergics and their potential link to Alzheimer’s and dementia. Anticholinergics are a common class of drug that includes some allergy medications, sleeping pills and many more common medicines.

Dr. Campbell recently received a $3.3 million grant from the National Institute on Aging to conduct the first clinical trial designed to determine if stopping these medications results in sustained improvements in cognition.

Listen to his discussion with the Caregiver Crossing hosts and his advice for people who are taking these medications.

Segment 1

 

Segment 2

Click here for more information on Caregiver Crossing.

Related News

Mar 05, 2021 • News
More than 2/3 of Indiana nursing home staff would take COVID-19 vaccine
Educating staff is crucial for increasing uptake and achieving desired results In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future. The study was led by researchers from Regenstrief Institute, Indiana University and…
Continue Reading >
Mar 02, 2021 • News
Second online survey launched by Regenstrief, IU to help gather COVID-19 data
Data shows willingness to get vaccine, reaches at-risk population   Regenstrief Institute and Indiana University launched a second online survey to gather data about COVID-19 symptoms, behaviors, and vaccine attitudes following the success of a pilot project. The questionnaire allows researchers to gather large quantities of data from across the U.S. quickly.   The pilot survey went online in April 2020 with questions about individuals’ COVID-19 symptoms, general location and travel history. It was distributed via banner ads on…
Continue Reading >